Janssen seeks expanded use of IMBRUVICA®▼ (ibrutinib) in two indications in Europe
- EMEA Innovative Medicine
- Janssen seeks expanded use of IMBRUVICA®▼ (ibrutinib) in two indications in Europe
Janssen seeks expanded use of IMBRUVICA®▼ (ibrutinib) in two indications in Europe
- X (Twitter)
Copy link